Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Futura Medical PLC

http://www.futuramedical.co.uk

Latest From Futura Medical PLC

Stock Watch: Lilly’s Emgality Trod A Well-Beaten Path To Clinical Failure

The outcome of any clinical study is uncertain but the choice of active comparator and sometimes even the placebo arm can magnify unpredictability. Emgality’s recent head-to-head failure in migraine is just the latest in a long list of casualties.

Stock Watch Clinical Trials

Appointments: Changes At Hikma, Bluebird Bio, Celgene, Alkermes, Cell Medica, Editas Medicine, Futura Medical, Corline Biomedical And Horizon Discovery

Pharma and biotech appointments this week include a new CEO at Hikma and an interim-CEO at Horizon Discovery, a Chief Commercial Officer for bluebird bio, and new board directors at Celgene, Alkermes, Editas Medicine, and Futura Medical.

Executive Changes Companies

Church & Dwight More Avid About Consumer Health Growth

The Vitafusion adult vitamins and L'il Critters multivitamins, fiber and omega-3 supplements for children far surpassed overall category growth of about 8% in the quarter, says CEO James Craigie, citing Nielsen data. Net income for the firm’s latest quarter period grew more than 12% to nearly $108 million.

Consumer Middle East and Africa

Church & Dwight More Avid About Consumer Health Growth

The Vitafusion adult vitamins and L'il Critters multivitamins, fiber and omega-3 supplements for children far surpassed overall category growth of about 8% in the quarter, says CEO James Craigie, citing Nielsen data. Net income for the firm’s latest quarter period grew more than 12% to nearly $108 million.

Consumer Middle East and Africa
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • OTC, Consumer
    • Drug Delivery
      • Topical Delivery
      • Transdermal
UsernamePublicRestriction

Register